Novartis cell-culture influenza virus vaccine wins FDA nod
The manufacturing method used for Flucelvax vaccine, indicated for adults of 18 years of age or older, allows for quicker vaccine production. Cell-culture technology requires well-characterized mammalian cell
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.